EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer This study was undertaken to determine the magnitude of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results